CI Investments Inc. reduced its stake in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 49.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 259 shares of the medical device company’s stock after selling 257 shares during the quarter. CI Investments Inc.’s holdings in Cooper Companies were worth $108,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of COO. MAI Capital Management boosted its holdings in Cooper Companies by 0.9% during the fourth quarter. MAI Capital Management now owns 3,236 shares of the medical device company’s stock worth $1,356,000 after purchasing an additional 28 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Cooper Companies by 12.9% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 263 shares of the medical device company’s stock valued at $110,000 after acquiring an additional 30 shares in the last quarter. Veritable L.P. grew its holdings in shares of Cooper Companies by 3.4% in the first quarter. Veritable L.P. now owns 972 shares of the medical device company’s stock valued at $406,000 after acquiring an additional 32 shares in the last quarter. Koshinski Asset Management Inc. increased its position in shares of Cooper Companies by 17.0% during the first quarter. Koshinski Asset Management Inc. now owns 248 shares of the medical device company’s stock valued at $104,000 after acquiring an additional 36 shares during the last quarter. Finally, Greenleaf Trust lifted its holdings in Cooper Companies by 6.5% during the first quarter. Greenleaf Trust now owns 591 shares of the medical device company’s stock worth $247,000 after acquiring an additional 36 shares during the period. 97.09% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on COO shares. KeyCorp decreased their target price on Cooper Companies from $414.00 to $408.00 and set an “overweight” rating for the company in a research report on Friday, June 3rd. Stifel Nicolaus dropped their target price on shares of Cooper Companies from $475.00 to $450.00 in a research note on Monday, June 6th. Citigroup decreased their price target on shares of Cooper Companies from $406.00 to $350.00 and set a “buy” rating for the company in a research note on Thursday, September 1st. Stephens dropped their price objective on Cooper Companies from $500.00 to $460.00 and set an “overweight” rating on the stock in a research note on Friday, June 3rd. Finally, Robert W. Baird decreased their target price on Cooper Companies from $375.00 to $345.00 and set a “neutral” rating for the company in a research report on Thursday, September 1st. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and a consensus target price of $406.00.
Cooper Companies Price Performance
Cooper Companies stock opened at $306.11 on Thursday. The firm has a market capitalization of $15.11 billion, a P/E ratio of 35.39, a PEG ratio of 2.30 and a beta of 0.93. The Cooper Companies, Inc. has a one year low of $283.03 and a one year high of $456.00. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.16 and a quick ratio of 0.71. The business has a fifty day moving average price of $313.23 and a 200-day moving average price of $350.87.
Cooper Companies (NYSE:COO – Get Rating) last issued its earnings results on Wednesday, August 31st. The medical device company reported $3.19 EPS for the quarter, missing the consensus estimate of $3.24 by ($0.05). Cooper Companies had a return on equity of 9.22% and a net margin of 13.38%. The company had revenue of $843.40 million during the quarter, compared to the consensus estimate of $830.22 million. During the same quarter in the prior year, the business earned $3.41 EPS. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 12.84 EPS for the current year.
Cooper Companies Dividend Announcement
The company also recently announced a semi-annual dividend, which was paid on Thursday, August 11th. Shareholders of record on Wednesday, July 27th were paid a $0.03 dividend. The ex-dividend date of this dividend was Tuesday, July 26th. Cooper Companies’s dividend payout ratio is presently 0.69%.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Receive News & Ratings for Cooper Companies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cooper Companies and related companies with MarketBeat.com’s FREE daily email newsletter.